Correlation Between Vivos Therapeutics and Motus GI
Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Motus GI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Motus GI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivos Therapeutics and Motus GI Holdings, you can compare the effects of market volatilities on Vivos Therapeutics and Motus GI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Motus GI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Motus GI.
Diversification Opportunities for Vivos Therapeutics and Motus GI
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Vivos and Motus is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Motus GI Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Motus GI Holdings and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Motus GI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Motus GI Holdings has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Motus GI go up and down completely randomly.
Pair Corralation between Vivos Therapeutics and Motus GI
If you would invest 268.00 in Vivos Therapeutics on September 2, 2024 and sell it today you would earn a total of 73.00 from holding Vivos Therapeutics or generate 27.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 4.76% |
Values | Daily Returns |
Vivos Therapeutics vs. Motus GI Holdings
Performance |
Timeline |
Vivos Therapeutics |
Motus GI Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vivos Therapeutics and Motus GI Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vivos Therapeutics and Motus GI
The main advantage of trading using opposite Vivos Therapeutics and Motus GI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Motus GI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Motus GI will offset losses from the drop in Motus GI's long position.Vivos Therapeutics vs. Bone Biologics Corp | Vivos Therapeutics vs. Tivic Health Systems | Vivos Therapeutics vs. Bluejay Diagnostics | Vivos Therapeutics vs. Rapid Micro Biosystems |
Motus GI vs. ENDRA Life Sciences | Motus GI vs. Electrocore LLC | Motus GI vs. Aileron Therapeutics | Motus GI vs. Check Cap |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |